Abstract 4624: The sTRA glycan is complementary to CA19-9 as a serologic biomarker of pancreatic cancer Article

Liu, Ying, Barnett, Daniel, Staal, Ben et al. (2018). Abstract 4624: The sTRA glycan is complementary to CA19-9 as a serologic biomarker of pancreatic cancer . CANCER RESEARCH, 78(13_Supplement), 4624-4624. 10.1158/1538-7445.am2018-4624

cited authors

  • Liu, Ying; Barnett, Daniel; Staal, Ben; Huang, Ying; Partyka, Katie; Zeh, Herbert; Singhi, Aatur; Drake, Richard R; Brand, Randall E; Haab, Brian B

authors

publication date

  • July 1, 2018

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 4.1 Discovery and preclinical testing of markers and technologies
  • Cancer
  • Clinical Research
  • Digestive Diseases
  • Orphan Drug
  • Pancreatic Cancer
  • Prevention
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Association for Cancer Research (AACR)

start page

  • 4624

end page

  • 4624

volume

  • 78

issue

  • 13_Supplement